We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Information about new funding to local councils to help them improve their drug and alcohol treatment and recovery systems.
Advice for prescribers on the risk of misuse of pregabalin and gabapentin, and suggestions for a balanced and rational use of these medicines.
This chart shows the regulation of precursor chemicals in the UK.
Resource for commissioners, providers and clinicians to identify the essential functions of addiction specialist doctors in recovery oriented treatment.
Document outlining the National Combating Drugs Outcome Framework, including supporting metrics to monitor progress towards the outcomes in From Harm to Hope.
Incident planning for potent synthetic opioids arriving into the illicit drug market.
From 8 November 2023 Nitrous Oxide is controlled as a Class C drug under the Misuse of Drugs Act 1971 and placed in Schedule 5 to the Misuse of Drugs Regulations 2001.
Guidance on commissioning and providing injectable opioid treatment for people with opioid dependence who have not responded to oral treatment.
If you are a UK citizen travelling abroad, you may wish to check other countries’ import regulations on controlled drugs.
Self-assessment tool, good-practice examples and resources for community drug treatment services to help them deliver OST in line with clinical guidance.
The Home Secretary has accepted the ACMD’s recommendation to reclassify methylamphetamine to a Class A Drug. Methylamphetamine (commonly referred…
Advice for drug treatment and recovery workers to help them to deliver safe and effective OST to service users.
Evidence and guidance to help health professionals identify, prevent or reduce drug-related harm.
PHE NW Education, Training and Employment (ETE) forum advise on considerations for ETE support for clients in drug and alcohol treatment.
A tool to help local areas carry out a self-assessment to improve the continuity of care for people leaving prison who need alcohol and drug treatment.
This guide is about infections that occur in people who inject drugs (PWID).
Guidance on supporting lived experience initiatives and recovery support services to help people start and sustain recovery from problem drug and alcohol use.
Guidance on commissioning and providing better care for people with co-occurring mental health, and alcohol and drug use conditions.
Information for NHS and public health professionals focusing on the life course approach which aims to give people fairer life chances.
Explains regulations that widen the availability of naloxone, a drug used as an antidote for heroin (or other opiate) overdoses.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).